Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
Authors
Keywords
-
Journal
PPAR Research
Volume 2018, Issue -, Pages 1-20
Publisher
Hindawi Limited
Online
2018-10-22
DOI
10.1155/2018/2010675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes
- (2018) Julio Barrera et al. PLoS One
- MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
- (2018) Maximilian Pohland et al. Alzheimers Research & Therapy
- NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies
- (2018) Caixia Zhang et al. Frontiers in Aging Neuroscience
- Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease
- (2018) NibaldoC Inestrosa et al. Neural Regeneration Research
- High Concentrations of Rosiglitazone Reduce mRNA and Protein Levels of LRP1 in HepG2 Cells
- (2017) Alejandro N. Rondón-Ortiz et al. Frontiers in Pharmacology
- M2 Phenotype Microglia-derived Cytokine Stimulates Proliferation and Neuronal Differentiation of Endogenous Stem Cells in Ischemic Brain
- (2017) Ja Yong Choi et al. Experimental Neurobiology
- PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β
- (2016) Xuefei Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
- (2016) Ming Tong et al. JOURNAL OF ALZHEIMERS DISEASE
- Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer’s Disease
- (2016) Suzanne M. de la Monte et al. JOURNAL OF ALZHEIMERS DISEASE
- Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis
- (2016) Pedro Cisternas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The rise and fall of insulin signaling in Alzheimer’s disease
- (2016) B. Chami et al. METABOLIC BRAIN DISEASE
- A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging
- (2016) A. Payton et al. NEUROBIOLOGY OF AGING
- A novel small-molecule agonist of PPAR-γ potentiates an anti-inflammatory M2 glial phenotype
- (2016) Gyun Jee Song et al. NEUROPHARMACOLOGY
- PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
- (2016) Loukia Katsouri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
- (2016) Isaac G. Onyango et al. Aging and Disease
- Effect of pioglitazone medication on the incidence of dementia
- (2015) Michael T. Heneka et al. ANNALS OF NEUROLOGY
- Role of Matrix Metalloproteinases in Animal Models of Ischemic Stroke
- (2015) Sebastien Lenglet et al. Current Vascular Pharmacology
- The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis
- (2015) Huawei Cheng et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage
- (2015) Santiago Garcia-Vallvé et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection
- (2015) Erwan Thouennon et al. JOURNAL OF NEUROCHEMISTRY
- Rosiglitazone, but Not Epigallocatechin-3-Gallate, Attenuates the Decrease in PGC-1α Protein Levels in Palmitate-Induced Insulin-Resistant C2C12 Cells
- (2015) Mohammad Hassan Karimfar et al. LIPIDS
- GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
- (2015) Ethan A Winkler et al. NATURE NEUROSCIENCE
- Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression
- (2015) Thiruchelvam Kariharan et al. NEUROBIOLOGY OF AGING
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1
- (2015) Anita Ramanathan et al. Frontiers in Aging Neuroscience
- Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
- (2015) Jinan Chen et al. PLoS One
- Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
- (2014) Sergio T. Ferreira et al. Alzheimers & Dementia
- The cis-regulatory effect of an Alzheimer’s disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes
- (2014) Colton Linnertz et al. Alzheimers & Dementia
- Peroxisome Proliferator-Activated Receptor-Gamma Agonists for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
- (2014) Jia Liu et al. DRUGS & AGING
- Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
- (2014) Anna Mietelska-Porowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality
- (2014) Elias Utreras et al. Journal of Neuroinflammation
- Minireview: Challenges and Opportunities in Development of PPAR Agonists
- (2014) Matthew B. Wright et al. MOLECULAR ENDOCRINOLOGY
- Apoptosis in Alzheimer’s Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues
- (2014) M. Obulesu et al. NEUROCHEMICAL RESEARCH
- Wnt signaling in the nervous system and in Alzheimer's disease
- (2014) N. C. Inestrosa et al. Journal of Molecular Cell Biology
- An alternate binding site for PPARγ ligands
- (2014) Travis S. Hughes et al. Nature Communications
- Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway
- (2013) Ming-Chang Chiang et al. MITOCHONDRION
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition
- (2013) Brittany L. Adler et al. NEUROBIOLOGY OF AGING
- Role of Nuclear Receptor on Regulation of BDNF and Neuroinflammation in Hippocampus of β-Amyloid Animal Model of Alzheimer’s Disease
- (2013) Atish Prakash et al. NEUROTOXICITY RESEARCH
- Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?
- (2013) Juan M. Zolezzi et al. PLoS One
- Age-Dependent Modulation of Synaptic Plasticity and Insulin Mimetic Effect of Lipoic Acid on a Mouse Model of Alzheimer’s Disease
- (2013) Harsh Sancheti et al. PLoS One
- Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies
- (2013) Zhichun Chen et al. PROGRESS IN NEUROBIOLOGY
- Design, development and evaluation of novel dual PPARδ/PPARγ agonists
- (2012) Symon Gathiaka et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
- (2012) Li Qiang et al. CELL
- Energy Intake and Exercise as Determinants of Brain Health and Vulnerability to Injury and Disease
- (2012) Mark P. Mattson Cell Metabolism
- PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus
- (2012) Li-Ying Jiang et al. CNS Neuroscience & Therapeutics
- Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes
- (2012) W. Zheng et al. DIABETOLOGIA
- Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice
- (2012) Magali Dumont et al. HUMAN MOLECULAR GENETICS
- Sustained expression of PGC-1 in the rat nigrostriatal system selectively impairs dopaminergic function
- (2012) C. Ciron et al. HUMAN MOLECULAR GENETICS
- Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
- (2012) Céline Pirat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia
- (2012) Jae Hoon Moon et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- PPAR /RXR -Induced and CD36-Mediated Microglial Amyloid- Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
- (2012) M. Yamanaka et al. JOURNAL OF NEUROSCIENCE
- Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor- -Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
- (2012) S. Mandrekar-Colucci et al. JOURNAL OF NEUROSCIENCE
- Nerve growth factor: from the early discoveries to the potential clinical use
- (2012) Luigi Aloe et al. Journal of Translational Medicine
- Pgc-1α Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf
- (2012) Joanne Clark et al. PLoS One
- Ligand and Receptor Dynamics Contribute to the Mechanism of Graded PPARγ Agonism
- (2012) Travis S. Hughes et al. STRUCTURE
- Transcriptional integration of mitochondrial biogenesis
- (2012) Richard C. Scarpulla et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD and wild-type mice
- (2012) F Masciopinto et al. Cell Death & Disease
- Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
- (2011) Benjamin W Miller et al. ANNALS OF PHARMACOTHERAPY
- Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
- (2011) C. Harrington et al. Current Alzheimer Research
- PPARγ Agonist Improves Neuronal Insulin Receptor Function in Hippocampus and Brain Mitochondria Function in Rats with Insulin Resistance Induced by Long Term High-Fat Diets
- (2011) Noppamas Pipatpiboon et al. ENDOCRINOLOGY
- Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity
- (2011) Laura Guasch et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
- (2011) Guenter Haemmerle et al. NATURE MEDICINE
- CDK5 Is Essential for Soluble Amyloid β-Induced Degradation of GKAP and Remodeling of the Synaptic Actin Cytoskeleton
- (2011) Francesco Roselli et al. PLoS One
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
- (2010) David S. Geldmacher et al. ARCHIVES OF NEUROLOGY
- New Insights on the Mechanism of PPAR-targeted Drugs
- (2010) Uwe Grether et al. ChemMedChem
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) Michael Gold et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Sirtuin 3, a New Target of PGC-1α, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis
- (2010) Xingxing Kong et al. PLoS One
- Coactivators in PPAR-Regulated Gene Expression
- (2010) Navin Viswakarma et al. PPAR Research
- Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer
- (2010) Ioannis A Voutsadakis World Journal of Gastrointestinal Oncology
- Neurodegeneration in an Aβ-induced model of Alzheimer’s disease: the role of Cdk5
- (2009) Joao P. Lopes et al. AGING CELL
- Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation
- (2009) Linda Slanec Higgins et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of Dementia
- (2009) Weiping Qin et al. ARCHIVES OF NEUROLOGY
- PGC-1α and PGC-1β Regulate Mitochondrial Density in Neurons
- (2009) Przemyslaw Wareski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β
- (2009) Alessandro Michelucci et al. JOURNAL OF NEUROIMMUNOLOGY
- Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
- (2009) E M Toledo et al. MOLECULAR PSYCHIATRY
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
- (2009) Tomohiko Sato et al. NEUROBIOLOGY OF AGING
- Peroxisome proliferator-activated receptor gamma (PPARγ): Is the genomic activity the only answer?
- (2009) Michaela Luconi et al. STEROIDS
- Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats
- (2008) Asif R. Pathan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor Agonist
- (2008) N. Nicolakakis et al. JOURNAL OF NEUROSCIENCE
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
- (2008) Anna P. Lillis et al. PHYSIOLOGICAL REVIEWS
- Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
- (2007) Ramya Kapadia Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now